NCT06329726 Long-Term Behavioral and Cognitive Outcomes of Deep Brain Stimulation in Patients With Parkinson's Disease
| NCT ID | NCT06329726 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 52 participants |
| Start Date | 2021-12-13 |
| Primary Completion | 2031-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 52 participants in total. It began in 2021-12-13 with a primary completion date of 2031-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to evaluate the long-term effect of DBS-STN on cognitive and behavioral outcomes in Parkinson's disease (PD) patients. PD patients will be assessed over time using tests, questionnaires and standardized clinical scales. An initial assessment (T0) and annual follow-up assessments will be carried out for 5 years. Researchers will compare data collected from patients with DBS versus patients with best medical therapy.
Eligibility Criteria
Inclusion Criteria: * Parkinson's disease patients candidates for DBS of the subthalamic nucleus * Parkinson's disease patients with best medical treatment Exclusion Criteria: * patients unable to complete study assessments
Contact & Investigator
Francesca Mameli, Dr
PRINCIPAL INVESTIGATOR
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Frequently Asked Questions
Who can join the NCT06329726 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06329726 currently recruiting?
Yes, NCT06329726 is actively recruiting participants. Contact the research team at fabiana.ruggiero@policlinico.mi.it for enrollment information.
Where is the NCT06329726 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06329726 clinical trial?
NCT06329726 is sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. The principal investigator is Francesca Mameli, Dr at Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. The trial plans to enroll 52 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.